About
StemRad provides personal radiation-protection solutions. Its technology offers lifesaving protection from penetrating ionizing radiation, making the lives of first responders, military personnel, utility personnel, medical teams, and astronauts safer without compromising mission objectives. The company has developed the 360 Gamma, a wearable shield that provides lifesaving protection from gamma radiation. StemRads 360 Gamma lowers radiation exposure to the most critical radiosensitive organs, including the colon, stomach, and ovaries, significantly reducing the associated risks in accordance with the ALARA safety principle. The StemRad 360 Gamma is worn around the pelvic area, which contains the bodys largest concentration of bone marrow. StemRad is also the developer of AstroRad, personal protective equipment designed to be worn by astronauts beyond low Earth orbit. Co-developed by StemRad and Lockheed Martin, AstroRad protects bone marrow to prevent acute radiation sickness, but is further expanded to also protect the lungs, stomach, colon, breasts, and ovaries organs that are particularly vulnerable to the development of cancer due to chronic exposure to radiation.
Funding history · 3 rounds · $7.8M total
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is StemRad's primary focus?
- StemRad specializes in providing personal radiation-protection solutions, developing technology to shield individuals from penetrating ionizing radiation.
- What are StemRad's main products?
- StemRad has developed two primary products: the 360 Gamma, a wearable shield for protection against gamma radiation, and AstroRad, personal protective equipment for astronauts co-developed with Lockheed Martin.
- When was StemRad founded?
- StemRad was founded in October 2011.
- Where are StemRad's main offices located?
- StemRad's headquarters are in Tel Aviv-Yafo, Israel, with an additional office in Tampa, Florida, USA.
- What was StemRad's most recent funding round?
- StemRad completed a Series C funding round in December 2017, with Jeff Vinik as an investor. For full financing history, refer to startupim.
- What was a significant contract secured by StemRad in late 2023?
- In December 2023, StemRad secured a $4.5 million contract to provide radiation shielding for US troops against gamma radiation.
- Has StemRad received any grants?
- Yes, in June 2019, StemRad received a grant of $250,000 from the IIA (Israel Innovation Authority).
- What is the purpose of the AstroRad product?
- AstroRad is personal protective equipment designed for astronauts to be worn beyond low Earth orbit, protecting bone marrow, lungs, stomach, colon, breasts, and ovaries from radiation exposure.
- What is the employee count for StemRad?
- StemRad has an employee count in the range of 11-50, with an exact count of 18 employees.